Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Escitalopram in Chronic PTSD
NCT00736021Phase 4Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Escitalopram oxalate oral solution in post-traumatic stress disorder (PTSD), sponsored by Hadassah Medical Organization. Primary endpoint: Post-traumatic Stress Disorder Symptoms as recorded by the Clinicians Administered PTSD Scale at 12 weeks. Started Sep 2008; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00736021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736021.